Adicet Bio to Participate in a Fireside Chat at the Guggenheim 2nd Annual Healthcare Innovation Conference
Adicet Bio Announces First Patient Dosed in Phase 1 Clinical Trial of ADI-001 in Treatment-Refractory Rheumatoid Arthritis
Adicet Bio Announces Positive Preliminary Data from ADI-001 Phase 1 Study in Patients with Lupus Nephritis and Systemic Lupus Erythematosus
Adicet Bio Announces First Systemic Sclerosis Patient Dosed in Ongoing Phase 1 Clinical Trial of ADI-001 in Autoimmune Diseases
IBM and the Recording Academy Strike a Chord, Release New watsonx Digital Experiences for Fans and Members Around 2026 Grammy Awards®
Anaergia S.r.l. starting activities for additional C$25 million in Contracts for Two Projects in Spain
Anaergia S.r.l. starting activities for additional C$25 million in Contracts for Two Projects in Spain
Ovintiv to Host its 2025 Fourth Quarter and Year-End Results Conference Call and Webcast on February 24, 2026
